| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Legal and Complian | General Counsel | EVP, General Counsel &Sec.
2 companies
Loeb Gary is an EVP, General Counsel &Sec. at SGMO, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $3.9M at current prices.
Our model assigns Loeb Gary a middling insider score of 65/100, based on 4 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +20.5%.
Loeb Gary's largest disclosed position is in ISRG as EVP &Chief Legal and Complian, worth about $2.8M. The recent filings there lean toward selling, a net 5,800 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | ISRG Intuitive Surgical, Inc. | EVP &Chief Legal and Complian | Sell10b5-1 | 400 | $379.00 | $151,600.00 | -7.0% | - | - | |
| Jun 10, 2026 | ISRG Intuitive Surgical, Inc. | EVP &Chief Legal and Complian | Sell10b5-1 | 400 | $424.14 | $169,656.00 | -6.5% | -15.0% | - | |
| May 11, 2026 | ISRG Intuitive Surgical, Inc. | EVP &Chief Legal and Complian | Sell10b5-1 | 400 | $446.95 | $178,780.00 | -6.1% | -6.4% | - | |
| Apr 25, 2025 | ISRG Intuitive Surgical Inc | EVP &Chief Legal and Complian | Sell10b5-1 | 1,700 | $513.18 | $872,406.00 | -43.1% | -5.0% | -6.3% | |
| Feb 12, 2025 | ISRG Intuitive Surgical Inc | EVP &Chief Legal and Complian | Sale+OE10b5-1 | 2,600 | $583.79 | $1,517,854.00 | -45.0% | -4.4% | -18.8% | |
| Sep 9, 2024 | ISRG Intuitive Surgical Inc | General Counsel | Sell10b5-1 | 300 | $475.00 | $142,500.00 | -15.8% | +12.4% | -2.5% | |
| Mar 23, 2021 | SGMO Sangamo Therapeutics, Inc | EVP, General Counsel &Sec. | Sale+OE | 17,524 | $13.13 | $230,041.96 | -17.4% | -8.1% | -54.2% |